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ABSTRACT
BACKGROUND AND OBJECTIVES: Opioid-induced 
hyperalgesia is a topic not yet fully understood in terms of 
mechanisms, diagnosis, prevention and treatment. Thus, it 
seems of great importance to evaluate this phenomenon that 
negatively affects the treatment of pain. The purpose of this 
study was to describe what tools to use to evaluate periopera-
tive hyperalgesia. 
CONTENTS: Several methods have been suggested to evaluate 
opioid-induced hyperalgesia, such as measure of pain intensity, 
opioid consumption, and evaluation of secondary hyperalgesia 
with algometer and Von Frey monofilaments. The measurement 
of some substances, such as cytokines, glutamate, and dynorphin 
has also been used. 
CONCLUSION: There are several ways to evaluate opioid-
induced hiperalgesia, easily reproducible tests should be chosen 
and which have also been described in previous studies.
Keywords: Analgesic opioid, Evaluation, Hyperalgesia, Pain.
RESUMO
JUSTIFICATIVA E OBJETIVOS: A hiperalgesia induzida pelo 
opioide é um tema ainda não totalmente esclarecido do ponto de 
vista dos mecanismos, do diagnóstico, da prevenção e do trata-
mento. Assim, parece de grande importância a avaliação desse 
fenômeno que afeta de maneira negativa o tratamento da dor. 
O objetivo deste estudo foi descrever quais instrumentos utilizar 
para avaliar a hiperalgesia perioperatória. 
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CONTEÚDO: Vários métodos têm sido indicados para avaliar 
hiperalgesia induzida pelo opioide, tais como medida da inten-
sidade da dor, consumo de opioide, e avaliação da hiperalgesia 
secundária com algômetro e monofilamentos de Von Frey. A 
dosagem de certas substâncias, como citocinas, glutamato e di-
norfina, também tem sido utilizada. 
CONCLUSÃO: Existem diversas maneiras de avaliar a hiperal-
gesia induzida pelo opioide; portanto devem ser escolhidos testes 
de fácil reprodutibilidade e que também foram descritos em es-
tudos anteriores.
Descritores: Analgésico opioide, Avaliação, Dor, Hiperalgesia.
INTRODUCTION
Opioid-induced hyperalgesia (OIH) is a subject not totally 
explained in terms of mechanisms, diagnosis, prevention and 
management. There is no report in the literature on the in-
cidence of OIH; however this effect may be present in all 
individuals under opioids1-3.
This is a phenomenon present both during prolonged admin-
istration1,3,4 and during short periods of time2.
Different methods have been indicated to evaluate OIH, 
such as pain intensity measurement, opioid consumption 
and evaluation of secondary hyperalgesia with algometer 
and Von Frey monofilaments5. So it is critical to understand 
hyperalgesia evaluation methods, although many of them 
are still being used just in studies and patients at high risk 
of developing OIH.
This study aimed at describing which tools should be used to 
evaluate perioperative hyperalgesia.
PAIN INTENSITY
Pain measurement is a challenge due pain subjectivity and 
complexity. Pain intensity may be measured with one-dimen-
sional or multidimensional scales. One-dimensional scales 
are: numerical scale, using scores from zero to 10 or from 
zero to 100; verbal scale, using categories such as no pain, 
mild, moderate and severe pain; and visual analog scale, us-
ing a straight line where one edge represents no pain and the 
opposite edge the worst imaginable pain, and patients mark 
where they believe is current intensity6.
According to current pain concepts, nociceptive stimuli are 
modulated at spinal cord level before reaching supra-segmen-
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tal structures and pain is no longer seen as a direct response 
exclusively related to tissue injury extension. So, there are 
different pain dimensions: sensory-discriminative; affective-
emotional; autonomic reactions; and evaluative, being those 
scales called multidimensional scales, such as McGill pain 
questionnaire7 (MPQ).
MPQ was developed in 1975 by Melzack in the McGill Uni-
versity, Montreal, Canada, aiming at supplying qualitative 
pain measurements which could be statistically analyzed. This 
is one of the most widely used questionnaires in the clinical 
practice and evaluates sensory, affective, temporal and mis-
cellaneous qualities of pain, in addition to evaluating pain 
intensity. So it has well-established validity and reliability in-
dices, in addition to discriminative power among different 
pain components7.
ADDITIONAL ANALGESIA
For the most adequate postoperative analgesic dose quantifi-
cation, the most common is analgesic consumption by means 
of patient-controlled analgesia (PCA), being intravenous 
morphine the most widely used opioid (1-1.5mg bolus, 7-10 
min blockade interval and 30-40mg limit in 4h), avoiding 
fixed and when necessary doses, which are less effective8.
MONOFILAMENTS 
Hyperalgesia may be evaluated with Von Frey monofila-
ments5. Monofilaments to evaluate sensitivity started to be 
used in late 1800s by Von Frey, in studies on touch and pres-
sure using horse hairs of different diameters. As from Von 
Frey studies, other investigators have tried to improve the 
technique, among them Weinstein9.
By analyzing Weinstein studies9, Waylett-Rendall10 and Naafs 
& Dagne11 have noted the possibility of using a reduced num-
ber of monofilaments to evaluate peripheral sensitivity, with-
out impairing results and were the first to introduce and use 
nylon monofilaments with diagnostic purposes and to control 
loss of sensory function.
Von Frey filaments have been used to determine parameters 
such as tactile, mechanical, nociceptive and windup thresh-
olds5.
Several diseases have been evaluated with monofilaments, 
such as leprosy12, carpal tunnel syndrome13, brachial plexus 
injury14 and post-chemotherapy15.
Although initially described to evaluate peripheral nerve in-
juries, investigations with monofilaments have been carried 
out to evaluate sensitivity threshold and pain close to surgical 
incision.
Sensitivity response by Von Frey monofilaments allows the 
evaluation of pressure on skin. Its efficacy to detect anti-hy-
peralgesic effect was tested in animals16 and humans17. More-
over, monofilaments allow for postoperative hyperalgesia 
mapping and area delimitation18.
The use of nylon filaments with constant length but increas-
ing diameters, which tilt or bend when a certain pressure is 
reached, is the standard. This sensitivity evaluation procedure is 
sensitive and repeatable to detect peripheral nerve alterations19.
Hyperalgesia may be tested with Von Frey monofilaments 
consisting of a set of six nylon filaments with 38mm length 
and different diameters and weights (0.05g; 0.2g; 2g; 4g; 10g 
and 300g) (SORRI-BAURU®) (Table 1). Each monofilament 
is fixed to a rod, in 90o angle, and corresponds to a functional 
level represented by a color. Test may also be performed with 
a higher number of filaments; however the procedure is too 
lengthy and difficult.
For postoperative pain, mechanical pain threshold is evaluated 
before surgery and 24 hours after surgery to compare pre and 
postoperative sensitivity. The test starts with the lightest mono-
filament (green) and patients are asked to close their eyes and 
answer “yes” when feeling pain at monofilament touch.
Hyperalgesia is tested on the thenar eminence of the non-
dominant hand and on the peri-incisional region 2 cm apart 
from surgical incision. Thenar eminence is a place unrelated 
to surgical stimulation and where opioid hyperalgesia effect 
may be observed without influence of surgical incision hyper-
algesia. For chronic pain, hyperalgesia may also be tested on 
the thenar eminence, before and after opioid administration. 
Different monofilaments are applied with at least 30-second 
intervals to decrease early responses induced by previous stimu-
lation close to new stimulation. Three evaluations are carried 
out with the same monofilament. In the absence of response, 
the next heavier filament is applied (blue) and so on. Mono-
filament colors, in progressive order of application are: green, 
blue, violet, dark red, orange and magenta. When applying the 
test, patients’ perception of the contact with the rods deter-
mines sensitivity of the studied region. If patients do not report 
pain, the heaviest filament (300g) is considered pain threshold.
Skin is pressed until the filament bends and pressure is main-
tained for approximately one and a half seconds, without 
allowing the filament to slide on the skin. Mechanical pain 
threshold is determined when patients identify two of the 
three stimulations as painful.
Table 1. Monofilaments 
Types of monofilaments
Green 0.05g
Blue 0.2g
Violet 2g
Dark red 4g
Orange 10g
Magenta 300g
HYPERALGESIA EXTENSION
For postoperative pain, hyperalgesia extension is determined 
close to the incision. A filament from the monofilaments 
kit is used, depending on the selected kit and on how many 
grams the monofilament has, starting stimulation outside the 
hyperalgesia area, where no pain sensation is reported, and 
proceeding with stimulation at every 0.5cm until surgical 
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incision, in four points (upper, right lateral, left lateral and 
lower). The first point where patients report pain is marked. 
If no pain sensation is reported, stimulation ends at 0.5 cm 
from the incision.
The distance from each point to the surgical incision is mea-
sured and the sum of distances is determined5.
DYNAMIC ALLODYNIA
For postoperative pain, dynamic allodynia is evaluated with a 
smooth brush on the thenar eminence of the non-dominant 
hand and on the peri-incisional region. Allodynia is con-
firmed when stimulation induces obvious pain sensation5.
ALGOMETER
Mechanical pressure pain threshold on the thenar eminence 
of the non-dominant hand and periumbilical region may also 
be evaluated with algometer, tool which evaluates pressure on 
skin by gradually increasing 0.1Kgf.sec-1 5. Evaluation may be 
performed by different evaluators with the same reproduc-
tion capacity; however a mean of three evaluations should be 
performed20.
Algometer has been used to evaluate pressure threshold in dif-
ferent diseases. It is used to evaluate carpal tunnel syndrome13 
and other painful syndromes such as fibromyalgia, low back 
pain, myofascial syndrome and headache21-23.
Labor pain may be predicted by pressure threshold using the 
algometer24. Sensitivity threshold close to surgical incision 
has been also evaluated with algometer5,25.
Although widely used to evaluate sensitivity threshold in dif-
ferent clinical situations, one should take into consideration 
other characteristics, such as gender26, age and weight27, in 
addition to emotional characteristics28.
OTHER SENSORY TESTS
Other sensory tests (heat, cold, vibration and electric stimula-
tion) may be used to observe different sensitivity thresholds 
and to prove the effect of the studied drug. However these 
procedures cannot be reproduced due to the long time needed 
to perform them (>30 minutes), in addition to being difficult 
to be understood by patients29.
CYTOKINES DOSAGE
Pain is intrinsically related to the immune system in such 
a way that it is not totally understood whether nociception 
block decreases pro-inflammatory cytokines production or 
whether decreased pro-inflammatory cytokines production 
results in less severe pain30.
Cytokines may produce their effects locally or, when exces-
sively produced, may act as hormones, reaching blood flow. 
So, they are responsible for local or systemic responses, gen-
erating immune, metabolic, hemodynamic, endocrine and 
neural changes31.
These molecules may trigger short and long term effects, and 
may lead to chronic hyperexcitability and changes on noci-
ceptors expression, abnormal processing of painful stimula-
tions and exacerbation of painful processes32.
After tissue injury, first cytokines to be formed are IL-1β and 
TNF-α, which directly act on specific receptors of sensory 
neurons and lead to the synthesis of other cytokines, which 
in turn induce glial cells proliferation in the central nervous 
system with the release of pro-inflammatory cytokines30,32,33. 
Cytokines are related to OIH and may act as OIH markers.
Opioids are associated to increased pro-inflammatory cyto-
kines, which indirectly modulate pain by releasing substances 
such as nitric oxide, oxygen free radicals, prostaglandins, mi-
croglia excitatory amino acids and astrocytes. With this, there 
is N-methyl-D-aspartate (NMDA) receptors activation, induc-
ing peripheral and central sensitization and hyperalgesia1,3.
Cytokines are released between 2h and 4h after tissue injury, 
and magnitude depends on trauma extension33. First cyto-
kines released after tissue injury are TNF-α and IL-1. How-
ever IL-6 is considered the most relevant marker of tissue in-
jury level during surgery34.
After injury, IL-6 plasma concentrations are detectable within 
60 minutes, with peak between 4h and 6h and may persist 
for 10 days.
IL-8 production is stimulated by IL-6, with similar action 
peak, being described as a marker of different clinical condi-
tions, among them postoperative pain35.
Anti-inflammatory cytokines are molecules regulating in-
flammatory cytokines production, thus acting on immune 
response regulation. There are several anti-inflammatory cy-
tokines, such as IL-1 receptor inhibitor, IL-4, IL-10 and IL-
1335,36. However, IL-10 is the primary anti-inflammatory cy-
tokine, acting by inhibiting the production of IL-1, IL-6 and 
TNF-α30. Acute IL-10 administration suppresses pain facili-
tation in different animal models36 and chronic pain patients 
have low IL-4 and IL-10 levels37.
OTHER MARKERS
NMDA receptors activation by glutamate is implied in OIH 
mechanisms1,2. Increased glutamate release in spinal cord dor-
sal horn and sustained increase of NMDA receptors response 
seem to be the primary OIH mechanisms38,39.
OIH has been associated to increased cholecystokinin, which 
is a peptide related to calcitonin gene (CGRP), substance-P 
and nociceptin in ventromedial rostral spinal cord40.
A different mechanism involves facilitator descending path-
ways which are mediated via opioids in on cells located in 
the ventromedial rostral spinal cord40. Exposure to morphine 
causes neuroplastic ventromedial rostral spinal cord changes, 
descending facilitation via on cells, with increased dynorphin3.
Prostaglandins and chemokines may also be relevant for the 
development of OIH1,3. There is increased fos-C protein in 
spinal cord sensory neurons1,3. Nitric oxide synthase and he-
moxigenase systems may be involved in OIH1. Other possible 
mechanism would be decreased glicinergic inhibitory control1.
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CONCLUSION
There are many ways to evaluate OIH, however one should 
select tests which are easy to reproduce and which have also 
been described in previous studies, in addition to using more 
than one evaluation method.
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